427640.fig.002a
(a)
427640.fig.002b
(b)
Figure 2: The change in mean arterial pressure (MAP) from baseline in obese (a) and lean (b) SHR-cp during three weeks of vehicle or compound 11 (10 mg/kg/d) administration. compared to vehicle.